KIR3DL3 INHIBITORS AND IMMUNE CELL ACTIVATING AGENTS

The present disclosure pertains to KIR3DL3 inhibitors (e.g., anti-KIR3DL3 antibodies or antigen-binding fragments thereof) and immune cell activating agents and uses thereof, such as to modify immune effector cells. La présente divulgation concerne des inhibiteurs de KIR3DL3 (par exemple, des antico...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BINISZKIEWICZ, Detlev, CHAPPEL, Scott, ETEMAD-GILBERTSON, Bijan
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure pertains to KIR3DL3 inhibitors (e.g., anti-KIR3DL3 antibodies or antigen-binding fragments thereof) and immune cell activating agents and uses thereof, such as to modify immune effector cells. La présente divulgation concerne des inhibiteurs de KIR3DL3 (par exemple, des anticorps anti-KIR3DL3 ou des fragments de liaison à l'antigène de ceux-ci) et des agents d'activation de cellules immunitaires et leurs utilisations, de façon à modifier des cellules effectrices immunitaires.